Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases

M. de Boer, E. M. M. Adang, K. C. G. Van Dycke, J. A. A. M. van Dijck, G. F. Borm, S. C. Seferina, C. H. M. van Deurzen, P. J. van Diest, P. Bult, A. R. T. Donders, V. C. G. Tjan-Heijnen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)2585-2591
JournalAnnals of Oncology
Issue number10
Publication statusPublished - Oct 2012


  • adjuvant systemic therapy
  • breast cancer
  • cost-effectiveness
  • isolated tumor cells
  • micrometastases

Cite this